Edwards Lifesciences (EW) Cash from Operations Growth (3y) (2012 - 2026)
Edwards Lifesciences (EW) Cash from Operations Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.67 Bn | 194.07 Bn | 7.27 Bn | 27.41% |
| 2 | Stryker | 129.56 Bn | 126.09 Bn | 4.50 Bn | 22.38% |
| 3 | Medtronic | 119.87 Bn | 110.65 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 73.80 Bn | 73.27 Bn | 3.85 Bn | 30.85% |
| 5 | Edwards Lifesciences | 52.66 Bn | 48.41 Bn | 1.35 Bn | 168.71% |
| 6 | Dexcom | 34.56 Bn | 32.61 Bn | 830.00 Mn | 12.26% |
| 7 | GE HealthCare Technologies | 34.16 Bn | 32.05 Bn | 2.18 Bn | 65.19% |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 43.79% |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 9.30% |
| 10 | Zimmer Biomet Holdings | 19.35 Bn | 18.94 Bn | 1.54 Bn | 8.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 168.71% |
| Mar 31, 2026 | -48.14% |
| Dec 31, 2025 | 16.82% |
| Sep 30, 2025 | 22.79% |
| Jun 30, 2025 | -4.41% |
| Mar 31, 2025 | -1.49% |
| Dec 31, 2024 | -32.79% |
| Sep 30, 2024 | -12.87% |
| Jun 30, 2024 | -10.95% |
| Mar 31, 2024 | -29.62% |
| Dec 31, 2023 | -30.09% |
| Sep 30, 2023 | 23.95% |
| Jun 30, 2023 | -47.43% |
| Mar 31, 2023 | 14.89% |
| Dec 31, 2022 | -11.13% |
| Sep 30, 2022 | -10.84% |
| Jun 30, 2022 | -0.89% |
| Mar 31, 2022 | 480.42% |
| Dec 31, 2021 | 8.45% |
| Sep 30, 2021 | 15.83% |